文献速递产科母胎医学

按母亲生育力状态划分的妊娠、分娩和婴儿结局:马萨诸塞州辅助生殖技术结局研究

Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.
PubMed 文献 · Am J Obstet Gynecol · 2017-04-08

该研究链接2004-2010年马萨诸塞州居民单胎活产记录与医院出院及生命统计资料,将459623名妇女分为体外受精、低生育力和生育力正常三组,比较15项不良结局风险。低生育力和体外受精组多项妊娠及婴儿结局风险升高,体外受精组子宫出血和胎盘并发症风险最高。

要点

  • 低生育力组6项妊娠结局和6项婴儿结局风险升高,体外受精组分别为5项和7项。
  • 体外受精组子宫出血校正风险比3.80(95%CI 3.31-4.36),胎盘并发症2.81(95%CI 2.57-3.08)。
  • 体外受精婴儿极早产校正风险比2.13(95%CI 1.80-2.52),极低出生体重2.15(95%CI 1.80-2.56)。

核心结论

  • 与生育力正常妇女相比,低生育力和体外受精治疗妇女往往年龄更大、有更多既存慢性疾病,且不良妊娠结局风险更高,尤其是子宫出血和胎盘并发症。
  • 体外受精治疗妇女风险更高可能反映更严重的不孕症、更广泛的基础病理或本研究未测量的其他不利因素。

研究设计与样本

  • 研究链接2004-2010年马萨诸塞州居民所有≥22周妊娠且出生体重≥350 g的单胎活产与医院出院及生命统计资料。
  • 妇女按生育力状态分为体外受精组(分娩链接至辅助生殖技术临床结局报告系统的体外受精周期)、低生育力组(有低生育力指标但未接受体外受精治疗)和生育力正常组(无低生育力指标或体外受精治疗)。
  • 研究纳入459623名妇女,其中生育力正常组441420名、低生育力组8054名、体外受精组10149名。
  • 采用多变量对数二项回归模型,以生育力正常组为参照和以低生育力组为参照,报告校正风险比和95%置信区间。

主要发现

  • 低生育力组6项妊娠结局和9项婴儿结局中的6项风险升高;体外受精组6项妊娠结局中的5项和9项婴儿结局中的7项风险升高。
  • 体外受精组在6项妊娠结局中的4项(子宫出血、胎盘并发症、产前住院和初次剖宫产)以及2项婴儿结局(低出生体重和早产)风险高于低生育力组,置信区间不重叠。
  • 体外受精组子宫出血校正风险比3.80(95%CI 3.31-4.36),胎盘并发症校正风险比2.81(95%CI 2.57-3.08)。
  • 体外受精婴儿极早产校正风险比2.13(95%CI 1.80-2.52),极低出生体重校正风险比2.15(95%CI 1.80-2.56)。
  • 以低生育力组为参照,体外受精组子宫出血、胎盘并发症、产前住院、初次剖宫产、低出生体重和极低出生体重、早产和极早产风险显著增加。

局限性

  • 体外受精治疗妇女风险更高可能反映更严重的不孕症、更广泛的基础病理或本研究未测量的其他不利因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Births to subfertile women, with and without infertility treatment, have been reported to have lower birthweights and shorter gestations, even when limited to singletons. It is unknown whether these decrements are due to parental characteristics or aspects of infertility treatment. OBJECTIVE: The objective of the study was to evaluate the effect of maternal fertility status on the risk of pregnancy, birth, and infant complications. STUDY DESIGN: All singleton live births of ≥22 weeks' gestation and ≥350 g birthweight to Massachusetts resident women in 2004-2010 were linked to hospital discharge and vital records. Women were categorized by their fertility status as in vitro fertilization, subfertile, or fertile. Women whose births linked to in vitro fertilization cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System were classified as in vitro fertilization. Women with indicators of subfertility but not treated with in vitro fertilization were classified as subfertile. Women without indicators of subfertility or in vitro fertilization treatment were classified as fertile. Risks of 15 adverse outcomes (gestational diabetes, pregnancy hypertension, antenatal bleeding, placental complications [placenta abruptio and placenta previa], prenatal hospitalizations, primary cesarean delivery, very low birthweight [<1500 g], low birthweight [<2500 g], small-for-gestation birthweight [z-score ≤-1.28], large-for-gestation birthweight [z-score ≥1.28], very preterm [<32 weeks], preterm [<37 weeks], birth defects, neonatal death [0-27 days], and infant death [0-364 days of life]) were modeled by fertility status with the fertile group as reference and the subfertile group as reference, using multivariate log binomial regression and reported as adjusted risk ratios and 95% confidence intervals. RESULTS: The study population included 459,623 women (441,420 fertile, 8054 subfertile, and 10,149 in vitro fertilization). Women in the subfertile and in vitro fertilization groups were older than their fertile counterparts. Risks for 6 of 6 pregnancy outcomes and 6 of 9 infant outcomes were increased for the subfertile group, and 5 of 6 pregnancy outcomes and 7 of 9 infant outcomes were increased for the in vitro fertilization group. For 4 of the 6 pregnancy outcomes (uterine bleeding, placental complications, prenatal hospitalizations, and primary cesarean) and 2 of the infant outcomes (low birthweight and preterm) the risk was greater in the in vitro fertilization group, with nonoverlapping confidence intervals to the subfertile group, indicating a substantially higher risk among in vitro fertilization-treated women. The highest risks for the in vitro fertilization women were uterine bleeding (adjusted risk ratio, 3.80; 95% confidence interval, 3.31-4.36) and placental complications (adjusted risk ratio, 2.81; 95% confidence interval, 2.57-3.08), and for in vitro fertilization infants, very preterm birth (adjusted risk ratio, 2.13; 95% confidence interval, 1.80-2.52), and very low birthweight (adjusted risk ratio, 2.15; 95% confidence interval, 1.80-2.56). With subfertile women as reference, risks for the in vitro fertilization group were significantly increased for uterine bleeding, placental complications, prenatal hospitalizations, primary cesarean delivery, low and very low birthweight, and preterm and very preterm birth. CONCLUSION: These analyses indicate that, compared with fertile women, subfertile and in vitro fertilization-treated women tend to be older, have more preexisting chronic conditions, and are at higher risk for adverse pregnancy outcomes, particularly uterine bleeding and placental complications. The greater risk in in vitro fertilization-treated women may reflect more severe infertility, more extensive underlying pathology, or other unfavorable factors not measured in this study.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Luke B, Gopal D, Cabral H, et al. Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol. 2017. PMID: 28400311. doi:10.1016/j.ajog.2017.04.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。